T1D Medical Manager
About the job
- A relevant life-science degree (RS/MS) with a healthcare specialty is required.
- Prior experience managing clinical trials or studies and understanding relevant guidelines, such as Good Clinical Practice and ethics guidelines, is required.
- Fluency in Japanese and business-level English reading and writing are required.
- Scientific knowledge of the therapeutic area and experience in medical research and development are required.
- Analytical thinking and understanding of causation are required.
- Experience writing scientific medical papers, as appropriate, is required.
- Understanding the strategic needs of an affiliate organization is required to complete tasks.
- Ability to focus on scientific exchange, serve healthcare professional needs, gather feedback, and establish and maintain effective relationships is required.
- Written communication and presentation skills are required.
- Approachability and interpersonal savvy are required.
- Support the T1D Medical Head in developing and executing the Japan Medical Plan.
- Provide scientific input for promotional materials in collaboration with marketing.
- Collaborate with cross-functional teams to address unsolicited medical requests.
- Assist with regulatory interactions and development planning.
- Identify unmet medical needs to support lifecycle opportunities.
- Assist with publication planning and execution, including articles, congresses, and symposia.
- Engage with key opinion leaders and scientific societies to build networks.
- Support field strategy development with medical science liaisons and global medical teams.
- Develop medical content.
- Present data at advisory boards and scientific meetings.
- Collect and share medical insights with the Medical Head.
- Generate evidence by planning and executing company-sponsored studies and externally sponsored collaborations.
- Collaborate on post-approval study planning and execution.
- Review and support Investigator-Sponsored Studies.
- Analyze real-world data with internal and external experts.
- Operate independently while providing guidance to Medical Advisors.
- Navigate complex regulatory environments and ensure compliance.
- Manage national and international travel and a work schedule that is 40% remote and 60% onsite.
- Maintain scientific integrity in non-promotional activities.
- An advanced degree (MD, PhD, PharmD, or DNP in a medical specialty) is preferred.
- At least five years of experience in research and development and/or medical roles in pharmaceutical companies is preferred.
- At least two years of medical science liaison experience or three years as a Medical Manager or Medical Advisor is preferred.
- Understanding of health economics is preferred.
About the company
Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.
Company Size
10,001+
Company Stage
IPO
Headquarters
Paris, France
Founded
1973
Get referred to Sanofi
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
- June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
- Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.
What critics are saying
- Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
- Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
- Dupixent concentration makes 2030s patent loss an existential revenue shock.
What makes Sanofi unique
- Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
- October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
- Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Professional Development Budget
- Parental Leave